User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Feb 12 2015 14:44 IST RSS 2.0
 
1 to 20 of 2,542    
Obama Versus Obamacare: Acting at Big Pharma’s behest US president hurts India, others and his own legacy 12.2.2015 ET: Pharma
Latest negotiations with India – the leading source of generic drugs for developing countries – are a key part of this strategy.
Also found in: [+]
Big Pharma groupings urges US to ask India to change its IPR policies 12.2.2015 ET: Pharma
IPR issues, especially over drugs, have long been a sticky point in India-US bilateral relations which both countries are now trying to resolve.
Also found in: [+]
No question of 'appeasing' US or anyone else on IPR: Nirmala 9.2.2015 DNA: Top News
As the government readies its national IPR policy, Commerce and Industry Minister Nirmala Sitharaman said that there is no question of "appeasing" the US or anyone else. "Our IPR policy is in the making. The draft is out inviting inputs from all. No "trying to appease" anyone," she tweeted in reply to another tweet asking why India was trying to appease the US on Intellectual Property Rights (IPR). There are media reports that India is diluting its stand on issues such as data protection and patent linkage with the US. Recently, during the meeting of Sitharaman and US Commerce Secretary Penny Pritzker both the sides discussed IPR related issues. The minister invited comments from the US on the draft IPR policy, which was prepared with a six-member think tank. The US companies have alleged that India's IPR regime is discriminatory, particularly for pharmaceutical industry. But India has consistently maintained that its laws are compliant with global and WTO norms. The Commerce and Industry Ministry has ...
Also found in: [+]
Exports to reach Rs 1.1 lakh crore by FY'16 9.2.2015 ET: Foreign Trade
The pharmaceutical industry continues to benefit from lower cost of research and production which aids manufacturing for exports.
Also found in: [+]
Pharma exports to reach Rs 1.1 lakh crore by FY'16 9.2.2015 ET: Pharma
The pharmaceutical industry continues to benefit from lower cost of research and production which aids manufacturing for exports.
Also found in: [+]
HC asks patent office to review Gilead's case 3.2.2015 TOI: Cities
The Delhi high court has sent the decision of patent refusal for US firm Gilead's hepatitis C drug, Sovaldi, back to the patent office on procedural ...
Also found in: [+]
HC asks patent office to review Gilead’s case 3.2.2015 TOI: India Business
The Delhi high court has sent the decision of patent refusal for US firm Gilead’s hepatitis C drug, Sovaldi, back to the patent office on procedural grounds. The court’s decision is in response to Gilead’s writ petition seeking that the order rejecting its patent on the drug, be set aside.
Also found in: [+]
Patented drug price 30.1.2015 Telegraph: Nation
The drug price regulator has sought details of patented medicines as part of a drive to fix their rates.
Also found in: [+]
Duality finger at US drug patent call 29.1.2015 Telegraph: Nation
International health activists have joined their Indian counterparts in decrying what they say are Barack Obama's dual policy on big drug companies, pledging to break their stranglehold in the US but promoting their interests in India.
Also found in: [+]
Did PM concede to the US on IP and patents? 28.1.2015 India News, Latest News in India, Live News India, India Breaking News - Times of India
Reports of Prime Minister Narendra Modi telling a conclave of Indian and US corporate chiefs that India was ready to accept suggestions made by a joint working group with the United States on intellectual property rights has led to howls of protest and accusations of Indian selling out and bending to US ...
Also found in: [+]
Patent row no hurdle for Gilead Pharma’s Sovaldi launch 28.1.2015 ET: Pharma
Gilead Pharma says that the recent decision by the patent office, which rejected patent for one of its molecules, does not impact its India plans.
Also found in: [+]
Promote Indian drugs, US health groups urge Obama 27.1.2015 TOI: India
Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing “high-quality, low-cost generic medicines essential for health care around the ...
Also found in: [+]
India, US to enhance engagement on IPR 25.1.2015 Rediff: Business
India and the US on Sunday agreed to enhance their engagement on intellectual property rights, a vexed issue between the two countries.
Also found in: [+]
IPR and the great drug pricing dilemma 25.1.2015 TOI: India Business
The Obama visit could prove crucial for India's healthcare system. Intellectual property rights is listed as a priority area for discussion between the two nations, officials said.
Also found in: [+]
World backs India against ‘bully’ US 25.1.2015 TOI: Home
Apprehensive of the US exerting pressure on India to dilute the public health safeguards in its patent laws, organizations from across the world have signed a global petition supporting India’s patent law and urging India to stand strong in the face of “US bullying”.
Also found in: [+]
Government looks at Narendra Modi's charisma to strike deals with Obama 24.1.2015 DNA: Popular News
Even as the 'fortress' Delhi awaits US President Barack Obama, as well as First Lady Michelle Obama, officials here are banking on Prime Minister Narendra Modi's charisma to strike deals on key issues during the informal talks. It has appeared over past few days that glitches continue to haunt officials from both sides over a range of issues including climate change, totalisation, Visa, labour laws and intellectual property right (IPR), new defence cooperation agreement or revisiting liability regimes in the nuclear energy issue. The Prime Minister will get opportunities at least seven times during the next three days to hold informal discussions with the visiting US President, besides a formal bilateral dialogue that takes place in Hyderabad House here Sunday afternoon. Both will come face-to-face at least on seven different occasions between Sunday and Tuesday. Experts here believe Modi will also have to do a fine balancing act between regaling Americans and not succumbing to their pressures with ...
Also found in: [+]
India's patent laws under threat? 24.1.2015 India News, Latest News in India, Live News India, India Breaking News - Times of India
Setting up of a bilateral mechanism on intellectual property (IP) rights through the US-India trade policy forum and the new draft national IP policy championing IP as the only way to promote innovation have raised apprehensions among health activists that India might concede ground on IP during President Obama's ...
Also found in: [+]
Patients' groups voice patent fears 24.1.2015 Telegraph: Nation
Health and patients' rights groups have called on the government to resist American pressure that they claimed was aimed at weakening safeguards in India's patent laws that allow drug companies to sell inexpensive generic medicine.
Also found in: [+]
Government may negotiate price of patented drugs before market entry 23.1.2015 ET: Pharma
The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India.
Also found in: [+]
Govt may negotiate price of drugs before market entry 23.1.2015 TOI: India
The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in ...
Also found in: [+]
1 to 20 of 2,542